RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.4B
AUM Growth
+$1.32B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$208M
2
+$27.9M
3
+$25.7M
4
URGN icon
UroGen Pharma
URGN
+$20.8M
5
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$11.8M

Top Sells

1
+$62.6M
2
+$61M
3
+$42.6M
4
SLNO icon
Soleno Therapeutics
SLNO
+$36.6M
5
VRDN icon
Viridian Therapeutics
VRDN
+$30.8M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$17.3M 0.27%
+421,348
52
$17.1M 0.27%
+1,500,000
53
$14.5M 0.23%
800,000
54
$11.6M 0.18%
2,744,270
-7,860,074
55
$11.3M 0.18%
1,286,000
56
$9.91M 0.15%
3,525,754
57
$8.47M 0.13%
8,800,000
+2,298,376
58
$7.79M 0.12%
937,500
59
$3.61M 0.06%
3,062,871
-3,928,132
60
$3.01M 0.05%
347,069
61
$1.63M 0.03%
+237,408
62
$1.04M 0.02%
333,333
63
– –
-4,398,453
64
– –
-1,400,001
65
– –
-2,007,946
66
– –
-1,723,373
67
– –
-6,416,147
68
– –
-3,370,506
69
– –
-1,246,667
70
– –
-1,239,000
71
– –
-240,324
1 2
3